Delcath Systems Inc (DCTH) - Cumulative Company Assets

This chart of Delcath Systems, Inc. (DCTH) total asset value on the GURU.Markets platform, which stands at 126.19, illustrates the business development of filters for local drug delivery to the liver. High barriers to entry are ensured by exclusive patents and stringent FDA oversight. Furthermore, the issuer's financial success does not depend on macroeconomics but relies exclusively on the implementation of innovative perfusion systems.

Investors utilize this metric as an indicator of the issuer's overall resource base and financial stability, specifically for Delcath Systems, Inc. (DCTH). The metric is calculated inversely via return on assets (ROA), determining the aggregate of controlled assets and liabilities. The price action in the valuation of the company's financial assets signals the pace of capital expansion or contraction. The stability of this value is supported by the flawless technical condition and planned capacity utilization of the perfusion system assembly plants.